Global Health and Access Addressing health challenges for all
Using our expertise, global partnerships, and strategic access programs, we are making our products accessible to patients globally.
We believe that access to cancer diagnosis and treatment is a critical part of the global response to address health challenges in countries with limited access to radiopharmaceuticals.
Expanding Global Access to Cancer Care
In the field of nuclear medicine, radioligand therapy is just beginning to gain momentum for the treatment of cancer with the recent market launch of the first approved products. However, many patients and non-nuclear practitioners remain unaware of the existence of this technology.
Raising awareness about the different ways nuclear medicine can work and advancing global access to radiopharmaceutical therapy is a key to enhancing their development globally.
The Oncidium foundation is a non-profit, public-benefit organization dedicated to advancing radioligand therapy for cancer care worldwide. They focus on education, awareness, and advocating for equitable access to treatment.
Together with Curium, Oncidium bridges care gaps and helps build an ecosystem that supports people living with cancer, regardless of geographical or financial barriers, offering hope for an improved quality of life.
For the second consecutive year, we are sponsoring Oncidium foundation to help them supply radiopharmaceuticals to patients with cancer in countries like Africa, India, Mexico and Brazil. Together with our vertically integrated supply chain and Oncidium’s contacts, we are making a difference to people’s lives who otherwise would not have early access to essential radiodiagnostics.
